FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA has approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, Inc. The approval updates the labeling/indication for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

SUPPL AP for ACTEMRA (TOCILIZUMAB)